MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coffman, B. L.
Right arrow Articles by Tephly, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coffman, B. L.
Right arrow Articles by Tephly, T. R.

Cloning and stable expression of a cDNA encoding a rat liver UDP- glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin

BL Coffman, MD Green, CD King and TR Tephly

Department of Pharmacology, University of Iowa, Iowa City 52242, USA.

A chicken anti-rat polyclonal antibody to a purified rat liver UDP- glucuronosyltransferase (UGT) with catalytic activity toward opioid substrates was used to screen a liver cDNA library prepared from phenobarbital-treated Wistar rats. A number of positive clones were obtained, and one of these clones, pM1, was further characterized. Clone pM1 was found to be a full length cDNA coding for a member of the rat UGT1 gene family. Specifically, pM1 represents the full length homologue of the Gunn rat liver pseudo-gene product UGT1.1P and, therefore, has been designated UGT1.1r. The cDNA insert has an open reading frame of 1605 base pairs, which codes for a protein of 535 amino acids and is flanked by 2 and 632 base pairs of 5' and 3' noncoding sequence, respectively. The deduced amino acid sequence of pM1 contains amino acid sequences identical to the amino-terminal and internal peptides of the purified rat liver opioid UGT and to sequences reported for a rat liver bilirubin UGT [FEBS Lett. 299:183-186 (1992)]. Stable expression of UGT1.1r in human embryonic kidney 293 cells showed that a protein with a subunit molecular mass (56 kDa) identical to that of the purified protein was produced. Expressed UGT1.1r protein catalyzed the glucuronidation of buprenorphine and bilirubin at high rates. Other opioids, such as nalorphine and morphine, were also substrates for the expressed UGT1.1r protein. These results show that bilirubin and opioids can be conjugated by the same rat liver UGT.

Volume 47, Issue 6, pp. 1101-1105, 06/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Y. Tochigi, N. Yamashiki, S. Ohgiya, S. Ganaha, and H. Yokota
ISOFORM-SPECIFIC EXPRESSION AND INDUCTION OF UDP-GLUCURONOSYLTRANSFERASE IN IMMUNOACTIVATED PERITONEAL MACROPHAGES OF THE RAT
Drug Metab. Dispos., September 1, 2005; 33(9): 1391 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus
CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-L. Fang, F. A. Beland, D. R. Doerge, D. Wiener, C. Guillemette, M. M. Marques, and P. Lazarus
Characterization of Benzo(a)pyrene-trans-7,8-dihydrodiol Glucuronidation by Human Tissue Microsomes and Overexpressed UDP-glucuronosyltransferase Enzymes
Cancer Res., April 1, 2002; 62(7): 1978 - 1986.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus
O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9
Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
B. L. Coffman, C. D. King, G. R. Rios, and T. R. Tephly
The Glucuronidation of Opioids, Other Xenobiotics, and Androgens by Human UGT2B7Y(268) and UGT2B7H(268)
Drug Metab. Dispos., January 1, 1998; 26(1): 73 - 77.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
F. P. Guengerich, A. Parikh, E. F. Johnson, T. H. Richardson, C. von Wachenfeldt, J. Cosme, F. Jung, C. P. Strassburg, M. P. Manns, R. H. Tukey, et al.
Heterologous Expression of Human Drug-metabolizing Enzymes
Drug Metab. Dispos., November 1, 1997; 25(11): 1234 - 1241.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
A. Radominska, J. M. Little, P. A. Lehman, V. Samokyszyn, G. R. Rios, C. D. King, M. D. Green, and T. R. Tephly
Glucuronidation of Retinoids by Rat Recombinant UDP: Glucuronosyltransferase 1.1 (Bilirubin UGT)
Drug Metab. Dispos., July 1, 1997; 25(7): 889 - 893.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
Y. Ishii, A. Takami, K. Tsuruda, A. Kurogi, H. Yamada, and K. Oguri
Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation. Production of Isoform-Selective Antipeptide Antibodies toward UGT1.1r and UGT2B1
Drug Metab. Dispos., February 1, 1997; 25(2): 163 - 167.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
C. D. King, G. R. Rios, M. D. Green, P. I. Mackenzie, and T. R. Tephly
Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
Drug Metab. Dispos., February 1, 1997; 25(2): 251 - 255.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics